Cargando…
CARP-1 functional mimetics are novel inhibitors of drug-resistant triple negative breast cancers
Doxorubicin and Cisplatin are the frontline therapeutics for treatment of the triple negative breast cancers (TNBCs). Emergence of drug-resistance often contributes to failure of drugs and poor prognosis, and thus necessitates development of new and improved modalities to treat TNBCs. We generated a...
Autores principales: | Cheriyan, Vino T., Muthu, Magesh, Patel, Ketan, Sekhar, Sreeja, Rajeswaran, Walajapet, Larsen, Scott D., Polin, Lisa, Levi, Edi, Singh, Mandip, Rishi, Arun K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5341985/ https://www.ncbi.nlm.nih.gov/pubmed/27687593 http://dx.doi.org/10.18632/oncotarget.12333 |
Ejemplares similares
-
Mechanisms of Neuroblastoma Cell Growth Inhibition by CARP-1 Functional Mimetics
por: Muthu, Magesh, et al.
Publicado: (2014) -
A CARP-1 functional mimetic compound is synergistic with BRAF-targeting in non-small cell lung cancers
por: Cheriyan, Vino T., et al.
Publicado: (2018) -
A CARP-1 functional mimetic loaded vitamin E-TPGS micellar nano-formulation for inhibition of renal cell carcinoma
por: Cheriyan, Vino T., et al.
Publicado: (2017) -
CARP-1 Functional Mimetics Are a Novel Class of Small Molecule Inhibitors of Malignant Pleural Mesothelioma Cells
por: Jamal, Shazia, et al.
Publicado: (2014) -
A H2AX–CARP-1 Interaction Regulates Apoptosis Signaling Following DNA Damage
por: Sekhar, Sreeja C., et al.
Publicado: (2019)